Exploring the potential of antibody-drug conjugate ABT-414 as a targeted therapy for recurrent glioblastoma, including clinical trial results and future directions.
Explore revolutionary approaches from personalized vaccines to ultrasound-enabled drug delivery that are forging new paths of hope in the fight against glioblastoma.